Lyphe Launches V Range: Affordable, Reliable, and Future-Ready Medical Cannabis
Lyphe has launched the V range of medical cannabis products. In this press release they provide all the key information.
Reporting on drug policy, enforcement and the drugs trade. 663 pieces.
Lyphe has launched the V range of medical cannabis products. In this press release they provide all the key information.
Discover how Germany's innovative cannabis pilot programme is reshaping regulation and driving industry growth.
Kamala Harris has declared that she will support cannabis legalisation in the US. What does this mean for the industry?
In this article we explore some new research which outlines the impact of stigma and inequality on medical cannabis patients in the UK.
In this article we examine if Ketamine use in young people is exploding as reported by The Guardian and The Times recently.
Discover the latest MHRA guidelines set to reshape the UK medical cannabis market, covering new regulations on product naming and packaging.
In this article we examine the traffic data from Medbud for August - giving us a snapshot of the UK medical cannabis market.
The UK government's use of stigmatising language like "zombie drug" in its communication about the xylazine ban is harmful.
"Learn how landlords risk breaching the Equality Act 2010 by restricting tenants' use of prescribed medical cannabis.
In this articles we explore how Trump's new position on cannabis might impact the US cannabis policy landscape.
Why Labours proposed disposable vape ban is a blow to harm reduction. We need empowerment not paternalism to reduce harm.
Overdose Awareness Day, observed annually on the 31st of August, is a critical event for raising awareness about the growing issue.
Can the UK medical cannabis market hit 300k patients by 2028? To do so we will need better growth than any other medical cannabis market.
Why Labour's proposed smoking ban is an attack on personal freedom and the pub trade. If you care about drug policy reform this is a concern.
Critical DEA cannabis hearing delayed due to 43,500 public comments. The decision could now sit with Trump or Harris
New Data Shows Legalisation Reduces Cannabis Use. The UK should follow suit and take note: Volteface opinion piece
Ukraine’s Medical Cannabis Laws Need to Reflect the Realities of War. In this opinion piece Paul North outlines what needs changing and why
This article takes a closer look at MedBud.wiki's UK medical cannabis data in June 2024, highlighting interesting market trends.
Cannabis Europa 2024 comes to London tomorrow! We’re looking forward to tuning into what will undoubtedly be a fantastic agenda.
Volteface How to thrive in a rapidly changing Europe? Industry News How to thrive in the European Cannabis industry
Paul and Katya sit down each week to discuss the most interesting news stories for the cannabis industry and drug policy.
This article takes a closer look at MedBud.wiki's UK medical cannabis data in May, highlighting interesting market trends.
There can be plenty of fear around the impact of and evidence around cannabis legalisation. This article breaks down some key policy factors.
The DEA finally announced their intention around the rescheduling of cannabis in the US earlier this month after lengthy speculation.